Table 3 Predictive factors for major complications at 30 post-operative days.

From: Perioperative fluids and complications after pancreatoduodenectomy within an enhanced recovery pathway

 

Univariable analysis

Multivariable analysis

OR

95% CI

p value

Adjusted OR

95% CI

p value

Age > 70 years

1.41

0.73–2.70

0.303

   

Gender (female)

0.35

0.18–0.66

0.001

0.39

0.19–0.79

0.009

BMI > 25 kg/m2

0.97

0.52–1.81

0.926

   

ASA III/IV

1.85

0.96–3.57

0.066

1.92

0.94–3.93

0.075

WHO performance > 0

4.58

1.28–16.41

0.019

5.63

1.46–21.71

0.012

Active smoking

0.91

0.45–1.83

0.781

   

Diabetes

0.70

0.30–1.64

0.41

   

Malignant tumor

1.36

0.54–3.44

0.521

   

Neoadjuvant chemotherapy

0.75

0.21–2.68

0.662

   

Soft pancreatic texture

1.55

0.79–3.02

0.201

   

Non-dilated pancreatic main duct

2.35

1.22–4.52

0.011

2.22

1.10–4.50

0.026

Length surgery > 300 min

1.14

0.60–2.17

0.697

   

Intraoperative blood loss > 400 ml

1.21

0.64–2.29

0.554

   

Venous resection

0.73

0.35–1.52

0.402

   

IV POD 0 ≥ 4400 ml

1.24

0.65–2.37

0.506

   
  1. OR: Odd ratio, CI : Confidence Interval; BMI, body mass index ; ASA, American Society of Anesthesiologists; WHO, World Health Organization ; IV: intravenous; POD, post-operative day.